Management Transition Agreement Sample Contracts
Exhibit 10 (a) MANAGEMENT TRANSITION AGREEMENT THIS MANAGEMENT TRANSITION AGREEMENT (this "Agreement"), is made as of the 5th day of August, 2002, between ESCO Technologies Inc., a Missouri corporation (the "Company" or "ESCO"), and Dennis J. Moore...Management Transition Agreement • August 7th, 2002 • Esco Technologies Inc • Search, detection, navagation, guidance, aeronautical sys • Missouri
Contract Type FiledAugust 7th, 2002 Company Industry Jurisdiction
MANAGEMENT TRANSITION AGREEMENTManagement Transition Agreement • November 7th, 2024 • Capstone Companies, Inc. • Electric lighting & wiring equipment • Florida
Contract Type FiledNovember 7th, 2024 Company Industry JurisdictionThis Management Transition Agreement, dated October 28, 2024 [signed October 31, 2024] (“Effective Date”), (“Agreement”) is made by Capstone Companies, Inc., a Florida corporation subject to the reporting requirements of the Securities Exchange Act of 1934 and with shares of its Common Stock, $0.0001 par value, (“Common Stock”) quoted on The OTC Markets Group, Inc. QB Venture Market (“OTCQB”), (“CCI”) and the person or entity identified in Exhibit One hereto (“Other Signatory” or “OS”). OS and CCI may also be referred to individually as a “party” and collectively as the “parties”.
JELD-WEN, Inc. Charlotte, NC 28202 USAManagement Transition Agreement • January 5th, 2017 • JELD-WEN Holding, Inc. • Millwood, veneer, plywood, & structural wood members • North Carolina
Contract Type FiledJanuary 5th, 2017 Company Industry JurisdictionIn this Management Transition Agreement (the “Agreement”), JELD-WEN, inc. (“JELD-WEN” or the “Company”) agrees to provide you with certain benefits in the event your employment is terminated without Cause in the twenty-four (24) month period from December 1, 2015 to November 30, 2017. In providing these benefits (the “Transition Benefits”), our mutual goal is to retain you in your current position and to ensure your ongoing cooperation and assistance for at least twelve ( 12) months should your employment be terminated without Cause.
COHERENT, INC. MANAGEMENT TRANSITION AGREEMENTManagement Transition Agreement • December 18th, 2002 • Coherent Inc • Laboratory analytical instruments • California
Contract Type FiledDecember 18th, 2002 Company Industry JurisdictionTHIS AGREEMENT is effective as of April 8, 2002 (the "Effective Date"), by and between Coherent, Inc. ("Coherent") and Robert J. Quillinan ("Quillinan").
COHERENT, INC. MANAGEMENT TRANSITION AGREEMENTManagement Transition Agreement • December 18th, 2002 • Coherent Inc • Laboratory analytical instruments • California
Contract Type FiledDecember 18th, 2002 Company Industry JurisdictionTHIS AGREEMENT is effective as of October 1, 2002 (the "Effective Date"), by and between Coherent, Inc. ("Coherent") and Bernard Couillaud ("Couillaud").
EXHIBIT 10.1 ------------ MANAGEMENT TRANSITION AGREEMENT This Management Transition Agreement (the "Agreement") is made as of February 1, 2005, by and between Alan R. MacDougall, (the "Employee") and Datawatch Corporation (the "Company"). This...Management Transition Agreement • February 4th, 2005 • Datawatch Corp • Services-prepackaged software • Massachusetts
Contract Type FiledFebruary 4th, 2005 Company Industry Jurisdiction
June 27, 2023Management Transition Agreement • June 27th, 2023 • Chimerix Inc • Pharmaceutical preparations
Contract Type FiledJune 27th, 2023 Company Industry
RECITALSManagement Transition Agreement • December 23rd, 1996 • Coherent Inc • Laboratory analytical instruments • California
Contract Type FiledDecember 23rd, 1996 Company Industry Jurisdiction
MANAGEMENT TRANSITION AGREEMENTManagement Transition Agreement • February 1st, 2006 • Seachange International Inc • Radio & tv broadcasting & communications equipment • Massachusetts
Contract Type FiledFebruary 1st, 2006 Company Industry JurisdictionThis Management Transition Agreement (the “Agreement”) is made as of January 30, 2006, by and between William L. Fiedler (the “Executive”) and SeaChange International, Inc. (the “Company”).
AMENDMENT NUMBER ONE TO THE MANAGEMENT TRANSITION AGREEMENTManagement Transition Agreement • November 7th, 2024 • Capstone Companies, Inc. • Electric lighting & wiring equipment • Florida
Contract Type FiledNovember 7th, 2024 Company Industry JurisdictionThis Amendment Number One, dated November 6, 2024, (“Amendment”) amends a certain Management Transition Agreement, dated October 28, 2024 (signed by the parties on October 31, 2024, being the Effective Date), (“Agreement”) made by Capstone Companies, Inc., a Florida corporation subject to the reporting requirements of the Securities Exchange Act of 1934 and with shares of its Common Stock, $0.0001 par value, (“Common Stock”) quoted on The OTC Markets Group, Inc. QB Venture Market (“OTCQB”), (“CCI”) and Coppermine Ventures, LLC, a private Maryland limited liability company, (“OS”). OS and CCI may also be referred to individually as a “party” and collectively as the “parties”. Any capitalized term used herein that is not defined in this Amendment shall have the meaning set forth in the Agreement.
Management Transition AgreementManagement Transition Agreement • January 14th, 2004 • Liberate Technologies • Services-prepackaged software
Contract Type FiledJanuary 14th, 2004 Company IndustryThis Management Transition Agreement (the “Agreement”) is effective as of September 30, 2003 (“Effective Date”), and confirms the agreement between Liberate Technologies (“Liberate”) and John Kent Walker (“Walker”) (each a “Party” and collectively the “Parties”) concerning the conclusion of Walker’s employment with Liberate, which shall occur upon a mutually agreeable date within the six-month period from the Effective Date or such earlier date as Liberate may designate (“Termination Date”).
MANAGEMENT TRANSITION AGREEMENTManagement Transition Agreement • October 18th, 2013 • Tetralogic Pharmaceuticals Corp • Pharmaceutical preparations • Pennsylvania
Contract Type FiledOctober 18th, 2013 Company Industry JurisdictionThis Agreement is being entered into as of the 12th day of August, 2013 by and between TetraLogic Pharmaceuticals Corporation (hereinafter “Company”), and Mr. John M. Gill (hereinafter “Gill”).